-
1
-
-
84904690965
-
-
Accessed on January 4
-
www.drugtopics.com. Accessed on January 4, 2013.
-
(2013)
-
-
-
2
-
-
0037178569
-
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention
-
Serruys PW, De Feyter P, Macaya C, Kokott N, Puel J, Vrolix M, et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention. JAMA 2002;287:3215-3222.
-
(2002)
JAMA
, vol.287
, pp. 3215-3222
-
-
Serruys, P.W.1
De Feyter, P.2
Macaya, C.3
Kokott, N.4
Puel, J.5
Vrolix, M.6
-
3
-
-
0035804846
-
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial
-
Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001;285:1711-1718.
-
(2001)
JAMA
, vol.285
, pp. 1711-1718
-
-
Schwartz, G.G.1
Olsson, A.G.2
Ezekowitz, M.D.3
Ganz, P.4
Oliver, M.F.5
Waters, D.6
-
5
-
-
16244384606
-
Statins and hepatotoxicity: focus on patients with fatty liver
-
Chalasani N. Statins and hepatotoxicity: focus on patients with fatty liver. Hepatology 2005;41:690.
-
(2005)
Hepatology
, vol.41
, pp. 690
-
-
Chalasani, N.1
-
7
-
-
78649625452
-
Drug-induced acute liver failure: results of a U.S. multicenter, prospective study
-
the Acute Liver Failure Study Group.
-
Reuben A, Koch DG, Lee WM, and the Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010;52:2065-2076.
-
(2010)
Hepatology
, vol.52
, pp. 2065-2076
-
-
Reuben, A.1
Koch, D.G.2
Lee, W.M.3
-
8
-
-
84878325626
-
Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland
-
Björsson ES, Bergmann OM, Bjornsson HK, Kvaran RB, Olafsson S. Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 2013;144:1419-1425.
-
(2013)
Gastroenterology
, vol.144
, pp. 1419-1425
-
-
Björsson, E.S.1
Bergmann, O.M.2
Bjornsson, H.K.3
Kvaran, R.B.4
Olafsson, S.5
-
9
-
-
84855970707
-
Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing
-
Björnsson E, Jacbosen E, Kalaitzakis E. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. J Hepatol 2012;56:374-380.
-
(2012)
J Hepatol
, vol.56
, pp. 374-380
-
-
Björnsson, E.1
Jacbosen, E.2
Kalaitzakis, E.3
-
10
-
-
58149347349
-
Drug Induced Liver Injury Network (DILIN) prospective study: rationale, design, and conduct
-
Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, et al. Drug Induced Liver Injury Network (DILIN) prospective study: rationale, design, and conduct. Drug Saf 2009;132:55-68.
-
(2009)
Drug Saf
, vol.132
, pp. 55-68
-
-
Fontana, R.J.1
Watkins, P.B.2
Bonkovsky, H.L.3
Chalasani, N.4
Davern, T.5
Serrano, J.6
-
11
-
-
57249086242
-
Causes, clinical features, and outcomes from a prospective study of drug induced liver injury in the United States
-
Chalasani N, Fontana RJ, Bonkvosky HL, Watkins PB, Davern T, Serrano J, et al. Causes, clinical features, and outcomes from a prospective study of drug induced liver injury in the United States. Gastroenterology 2008;135:1924-1934.
-
(2008)
Gastroenterology
, vol.135
, pp. 1924-1934
-
-
Chalasani, N.1
Fontana, R.J.2
Bonkvosky, H.L.3
Watkins, P.B.4
Davern, T.5
Serrano, J.6
-
12
-
-
80054848088
-
Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury
-
Davern TJ, Chalasani N, Fontana RJ, Hayashi PH, Protiva P, Kleiner DE, et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011;141:1665-1672.
-
(2011)
Gastroenterology
, vol.141
, pp. 1665-1672
-
-
Davern, T.J.1
Chalasani, N.2
Fontana, R.J.3
Hayashi, P.H.4
Protiva, P.5
Kleiner, D.E.6
-
14
-
-
84893699696
-
Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations
-
Kleiner DE, Chalasani N, Lee WM, Fontana RJ, Bonkovsky HL, Watkins PB, et al. Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. Hepatology 2014;59:661-670.
-
(2014)
Hepatology
, vol.59
, pp. 661-670
-
-
Kleiner, D.E.1
Chalasani, N.2
Lee, W.M.3
Fontana, R.J.4
Bonkovsky, H.L.5
Watkins, P.B.6
-
15
-
-
33748452682
-
Autoimmune hepatitis triggered by statins
-
Alla V, Abraham J, Siddiqui J, Raina D, Wu G, Chalasani N, et al. Autoimmune hepatitis triggered by statins. J Clin Gastroenterol 2006;40:757-761.
-
(2006)
J Clin Gastroenterol
, vol.40
, pp. 757-761
-
-
Alla, V.1
Abraham, J.2
Siddiqui, J.3
Raina, D.4
Wu, G.5
Chalasani, N.6
-
16
-
-
84904642205
-
-
Accessed on December 1
-
www.livertox.nih.gov. Accessed on December 1, 2013.
-
(2013)
-
-
-
17
-
-
0033594789
-
Atorvastatin-induced hepatitis with the absence of cross-toxicity with simvastatin
-
Nakad A, Bataille L, Hamoir V, Sempoux C, Horsman Y. Atorvastatin-induced hepatitis with the absence of cross-toxicity with simvastatin. Lancet 1999;353:1763-1764.
-
(1999)
Lancet
, vol.353
, pp. 1763-1764
-
-
Nakad, A.1
Bataille, L.2
Hamoir, V.3
Sempoux, C.4
Horsman, Y.5
-
18
-
-
19544375388
-
Evaluation of cases of severe statin-related transaminitis within a large health maintenance organization
-
Charles EC, Olson KL, Sandhoff BG, McClure DL, Merenich JA. Evaluation of cases of severe statin-related transaminitis within a large health maintenance organization. Am J Med 2005;118:618-624.
-
(2005)
Am J Med
, vol.118
, pp. 618-624
-
-
Charles, E.C.1
Olson, K.L.2
Sandhoff, B.G.3
McClure, D.L.4
Merenich, J.A.5
-
19
-
-
0346243737
-
Fatal liver failure with atorvastatin
-
Perger L, Kohler M, Fattinger K, Flury R, Meier PJ, Pauli-Magnus C. Fatal liver failure with atorvastatin. J Hepatol 2003;39:1095-1097.
-
(2003)
J Hepatol
, vol.39
, pp. 1095-1097
-
-
Perger, L.1
Kohler, M.2
Fattinger, K.3
Flury, R.4
Meier, P.J.5
Pauli-Magnus, C.6
-
21
-
-
0035991457
-
Acute cholestatic hepatitis after reinitiating treatment with atorvastatin
-
Ridruejo E, Mando OG. Acute cholestatic hepatitis after reinitiating treatment with atorvastatin. J Hepatol 2002;37:165-166.
-
(2002)
J Hepatol
, vol.37
, pp. 165-166
-
-
Ridruejo, E.1
Mando, O.G.2
-
22
-
-
35048875811
-
Marked elevation of liver transaminases after high-dose fluvastatin unmasks chronic hepatitis C: safety and rechallenge
-
Chen YW, Lai HW, Wang TD. Marked elevation of liver transaminases after high-dose fluvastatin unmasks chronic hepatitis C: safety and rechallenge. Acta Neurol Taiwan 2007;16:163-167.
-
(2007)
Acta Neurol Taiwan
, vol.16
, pp. 163-167
-
-
Chen, Y.W.1
Lai, H.W.2
Wang, T.D.3
|